Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Journal of Experimental & Clinical Cancer Research : CR|June 9, 2021
A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastomaVid Mlakar, Edouard Morel, Simona Jurkovic Mlakar, et al.BMC Cancer|August 15, 2009
Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancerVid Mlakar, Gasper Berginc, Metka Volavsek, et al.Melanoma Research|March 11, 2010
Metastatic potential of melanoma cells is not affected by electrochemotherapyVesna Todorovic, Gregor Sersa, Vid Mlakar, et al.Journal of Bacteriology|May 5, 2006
Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureusTomaz Koprivnjak, Vid Mlakar, Lindsey Swanson, et al.Cancers|January 23, 2024
17q Gain in Neuroblastoma: A Review of Clinical and Biological ImplicationsVid Mlakar, Isabelle Dupanloup, Fanny Gonzales, et al.Journal of Cellular and Molecular Medicine|March 31, 2015
ADRA2A is involved in neuro-endocrine regulation of bone resorptionVid Mlakar, Simona Jurkovic Mlakar, Janja Zupan, et al.Frontiers in Oncology|December 24, 2024
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11Vid Mlakar, Ina Oehme, Laurence Lesne, et al.Frontiers in Pharmacology|June 4, 2026
Cellular pharmacology of fludarabine: molecular determinants of transport and metabolismMourad Mseddi, Vid Mlakar, Yvonne Gloor, et al.Experimental & Molecular Medicine|August 15, 2019
Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosisKlemen Kodrič, Janja Zupan, Tilen Kranjc, et al.Scientific Reports|November 3, 2018
Epigenetic enzymes influenced by oxidative stress and hypoxia mimetic in osteoblasts are differentially expressed in patients with osteoporosis and osteoarthritisPeter Vrtačnik, Janja Zupan, Vid Mlakar, et al.Pageof 5